Nasus Pharma Names Interim CFO as Longtime Finance Chief ResignsTip Ranks·Aug 19 at 01:47 PMNSRX-1.44%
Nasus Pharma CFO Eyal Rubin to exit; finance director Oren Elmaliach named interim CFOPUBT·Aug 19 at 11:00 AMNSRX-1.44%
Nasus Pharma Reports First Half 2026 Financial Results and Provides Business Update | NSRX Stock NewsStockTitan·Aug 17 at 04:14 AMNSRX-1.44%
Nasus Pharma CEO and Director Brendan O’Grady files initial beneficial ownership statementPUBT·Jul 31 at 08:26 PMNSRX-1.44%
Nasus Pharma CEO Dan Benjamin Teleman acquires 6,550 shares for $20,305PUBT·Jun 22 at 11:13 AMNSRX-1.44%
Nasus Pharma to Participate in Upcoming Investor Conferences | NSRX Stock NewsStockTitan·May 1 at 05:15 AMNSRX-1.44%
Nasus Pharma (NYSEAMERICAN:NSRX) CEO Dan Benjamin Teleman Purchases 2,900 SharesMarket Beat·Apr 24 at 10:34 AMNSRX-1.44%
Pre-market hot trades in US stocks: Nasus Pharma up 8.23% in pre-market; POET Tech down 7.60% in pre-marketPrice Alert·Apr 23 at 01:13 PMNSRX-1.44%POET+2.18%
U.S. stock market movement update: Quantum technology sector rebounds strongly, Xanadu up nearly 49%, Huachen AI up over 44%Price Alert·Apr 22 at 08:00 PMXNDU-1.26%HCAI+2.02%
